Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Investor call to discuss the acquisition of Organon & Co.".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Investor call to discuss the acquisition of Organon & Co.".